On March 28, global life sciences company MDS (Toronto, Canada) closed on its $615 million acquisition of Molecular Devices (Sunnyvale, CA), a supplier of high-performance bioanalytical measurement systems. MDS completed the sell-off of its lab business a month earlier with the sale of MDS Diagnostic Services to Borealis Infrastructure Management for CAD$1.325 billion (US$1.142 billion). The company is now focused on analytical instruments, pharmaceutical contract research, medical isotopes for molecular imaging, and radiotherapeutics.

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

April 2007 - Table of Contents

LIR April 2007 (full PDF issue)

Financial Benchmarks at 10 Major Labs: Quest and LabCorp See Gains in Revenue and Profit Per Billable Test

Aetna’s Lab Is Quest, LabCorp Takes a Hit

Kennedy to Fast Track New Bill to Regulate Lab Tests

Decatur Memorial Hospital Laboratory Enters the Molecular World

Benchmarking the Major Labs

Genova Diagnostics Buys Texas Reference Lab

Beckman Coulter to Buy Biosite for $1.55 billion

CMS Continues Rolling Out Medically Unlikely Edits

MDS Completes $615M Purchase of Molecular Devices

Lab Stocks Rise 3% Led by Orchid and Clarient

Biggest Challenges for AP Practices